RNA splicing is a fundamental process in eukaryotes in which messenger RNA is prepared to be translated into a protein. Missense mutations in splicing factors can result in the creation of malformed proteins and are associated with a wide array of cancers. Neoantigens arising from somatic mutations in spliceosome genes represent ideal immunologic targets for personalized cancer immunotherapy.